S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer

Pancreatic cancer (PC) is a highly fatal and aggressive disease with its incidence and mortality quite discouraging. It is of great significance to construct an effective prognostic signature of PC and find the novel biomarker for the optimization of the clinical decision-making. Due to the crucial...

Full description

Bibliographic Details
Main Authors: Yuan Chen, Chengcheng Wang, Jianlu Song, Ruiyuan Xu, Rexiati Ruze, Yupei Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
S100A2
tumor microenvironment
immune cells
prognostic model
immunotherapy
PD-L1
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.758004/full

Similar Items

Similar Items